Physician

Rajendra Dahal, M.D.

According to 2025 Medicare claims, Rajendra Dahal, M.D. (NPI: 1205830981) practices nephrology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is KIDNEY CARE QUAD CITIES, LLC (NPI: 1720227994; TIN: 264169259) and primary practice location at 61201-5351. Dahal is affiliated with the IRCCO (ACO ID: A2619), Genesis Accountable Care Organization, LLC. (ACO ID: A4799), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Dahal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 581 traditional Medicare patients, billed 2,255 HCPCS/CPT codes, and received $242,223 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,680 prescription claims across 527 beneficiaries totaling $302,935 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2018 DME data shows 18 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $465,788 to $242,223. Similarly, Part D prescription costs have declined steadily, from $545,887 to $302,935. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,144	10,137	$465,788
2016	945	6,125	$347,325
2017	1,034	8,053	$371,468
2018	1,127	5,907	$398,542
2019	1,012	4,708	$405,614
2020	829	3,542	$340,419
2021	795	3,890	$376,112
2022	676	2,898	$287,696
2023	589	2,486	$265,616
2024	581	2,255	$242,223

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	625	5,780	$545,887
2016	667	5,540	$433,179
2017	679	5,563	$384,560
2018	686	5,390	$257,762
2019	626	4,705	$185,521
2020	549	3,760	$192,096
2021	548	3,424	$223,620
2022	530	3,550	$278,461
2023	501	3,357	$248,008
2024	527	3,680	$302,935

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	156	$61,690
2016	N/R	207	$71,721
2017	N/R	188	$66,325
2018	N/R	18	$226
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	153	172	$130
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	56	68	$100
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	139	266	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	350	582	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	172	757	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	86	4,459	$81,323
Auryxia	Ferric Citrate	17	690	$36,358
Velphoro	Sucroferric Oxyhydroxide	13	450	$24,089
Sevelamer Carbonate	Sevelamer Carbonate	90	4,381	$16,294
Lanthanum Carbonate	Lanthanum Carbonate	18	644	$12,075

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Rajendra Dahal, M.D.?

Tedicare shows public-source Medicare data for Rajendra Dahal, M.D. (NPI 1205830981), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajendra Dahal, M.D. have ACO affiliation data?

Rajendra Dahal, M.D. is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Rajendra Dahal, M.D.?

Rajendra Dahal, M.D. is linked to KIDNEY CARE QUAD CITIES, LLC (billing NPI 1720227994) in the available physician profile data.

Does Rajendra Dahal, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.